Composition

Each mL of concentrate contains 25 mg of bevacizumab*. Each 4 mL vial contains 100 mg of bevacizumab. Each 16 mL vial contains 400 mg of bevacizumab. *Bevacizumab is a recombinant humanised monoclonal antibody produced by DNA technology in Chinese Hamster Ovary cells  

ATC Code/ATCvet Code

L01FG01  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

16 mL x 1's (in glass vial)  

Product Description

Concentrate for solution for infusion. Clear to slightly opalescent, colourless to pale brown liquid

Manufacturer Name

Roche Diagnostics GmbH

Manufacturer Country

GERMANY  

Approval Date

2019-12-20  

Expiry Date

2024-12-27